Sentinel lymph node (SLN) mapping in endometrial cancer (EMCA) is rapidly gaining
acceptance in the clinical community. As compared to a full lymphadenectomy in every …

Abstract Background The randomized EORTC 10981-22023 AMAROS trial investigates
whether breast cancer patients with a tumor-positive sentinel node biopsy (SNB) are best …

Sentinel lymph node biopsy (SLNB) is the standard surgical procedure for the axilla in early
node-negative breast cancer. To date, the “gold standard” to localize the sentinel lymph …

Sentinel lymph node biopsy (SLNB) is still the standard of care for axillary nodal staging in
patients with invasive breast cancer (BC) and clinically negative lymph nodes (LNs). It …

Objective: To evaluate factors affecting sentinel lymph node (SLN) identification after
neoadjuvant chemotherapy (NAC) in patients with initial node-positive breast cancer …

Objective As our understanding of sentinel lymph node (SLN) mapping for endometrial
cancer (EC) evolves, tailoring the technique to individual patients at high risk for failed …

Objective: Sentinel lymph node biopsy (SLNB) with a superparamagnetic iron oxide (SPIO)
tracer was shown to be non-inferior to the standard combined technique in the SentiMAG …

Aims The gold standard for detection of Sentinel Lymph Nodes (SLN) is a combined
radioisotope and blue dye breast injection, using a gamma probe (GP). A new, non …

Purpose This study aimed to assess the efficacy of the combination of indocyanine green
(ICG) and methylene blue (MB) dye in early breast cancer patients undergoing sentinel …

Objective To identify predictors of unsuccessful sentinel lymph node (SLN) mapping in
patients with apparent early-stage endometrial cancer (EC) undergoing surgical staging with …